KeyBanc Assumes Coverage on Timken (TKR) at Buy; Top Mgmt Team
Get Alerts TKR Hot Sheet
Price: $88.14 --0%
Rating Summary:
6 Buy, 10 Hold, 1 Sell
Rating Trend: Up
Today's Overall Ratings:
Up: 12 | Down: 10 | New: 10
Rating Summary:
6 Buy, 10 Hold, 1 Sell
Rating Trend: Up
Today's Overall Ratings:
Up: 12 | Down: 10 | New: 10
Join SI Premium – FREE
KeyBanc assumes coverage on Timken (NYSE: TKR) with a Buy. PT $53.00.
KeyBanc analyst says, "Overall, we believe TKR benefits from a top tier management team and dominant market position in many applications (e.g., tapered roller bearings and SBQ steel) and should outperform its peers over the next 12-24 months as the shares more fully reflect the Company's recent initiatives. In our view, TKR is taking the right steps to generate sustainably higher levels of profitability through the cycle while reducing cyclicality by pursuing increased exposure to high growth industrial applications, emerging markets and aftermarket."
For an analyst ratings summary and ratings history on Timken click here. For more ratings news on Timken click here.
Shares of Timken closed at $40.58 yesterday.
KeyBanc analyst says, "Overall, we believe TKR benefits from a top tier management team and dominant market position in many applications (e.g., tapered roller bearings and SBQ steel) and should outperform its peers over the next 12-24 months as the shares more fully reflect the Company's recent initiatives. In our view, TKR is taking the right steps to generate sustainably higher levels of profitability through the cycle while reducing cyclicality by pursuing increased exposure to high growth industrial applications, emerging markets and aftermarket."
For an analyst ratings summary and ratings history on Timken click here. For more ratings news on Timken click here.
Shares of Timken closed at $40.58 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- William Blair Starts Bentley Systems Inc. (BSY) at Outperform, 'believe the company has several growth levers'
- William Blair Starts Solid Biosciences (SLDB) at Outperform, 'success in any of programs alone should provide severalfold upside from Solid’s current valuation'
- 29Metals Ltd (29M:AU) PT Lowered to AUD0.50 at RBC Capital
Create E-mail Alert Related Categories
New CoverageRelated Entities
KeyBancSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!